RhoVac AB

RhoVac utvecklar ett immunterapeutiskt läkemedel för behandling av metastaserande cancer. Läkemedlet samarbetar med kroppens immunförsvar och är riktat mot proteinet RhoC som är överuttryckt i alla metastaserande cancerceller.

Details & files

tegningsperiod:: 21/1 - 04/2 2016

Type:: IPO

Zieglers Gaard
Nybrogade 12
1203 København
@email
+45 70 60 55 62

Manage Cookie Consent

Vi bruger cookies til at forbedre vores tjenester og vores hjemmeside.

Funktionelle Funktionelle Altid aktiv

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Indstillinger

{title} {title} {title}